Open AccessReduction in Multiple Cardiometabolic Risk Factors With Combined Olanzapine/Samidorphan Compared With Olanzapine: Post Hoc Analyses From a 24-Week Phase 3 Study
Author(s) -
Christoph U. Correll,
Evan A. Stein,
Christine Graham,
Lauren DiPetrillo,
Sarah Akerman,
Arielle D. Stanford,
Ying Jiang,
Sergey Yagoda,
David McDonnell,
Craig Hopkinson
Publication year - 2022
Publication title -
schizophrenia bulletin
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.823
H-Index - 190
eISSN - 1745-1701
pISSN - 0586-7614
DOI - 10.1093/schbul/sbac144
Subject(s) - olanzapine , blood pressure , medicine , post hoc analysis , body mass index , odds ratio , hyperlipidemia , endocrinology , metabolic syndrome , obesity , gastroenterology , diabetes mellitus , schizophrenia (object oriented programming) , psychiatry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom